• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis. Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2

tetano

Editor, Senior Moderator
Emerg Infect Dis. 2020 Apr 15;26(7). doi: 10.3201/eid2607.201285. [Epub ahead of print]
Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2.


Waggoner JJ, Stittleburg V, Pond R, Saklawi Y, Sahoo MK, Babiker A, Hussaini L, Kraft CS, Pinsky BA, Anderson EJ, Rouphael N.

Abstract

Most reverse transcription PCR protocols for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) include 2-3 targets for detection. We developed a triplex, real-time reverse transcription PCR for SARS-CoV-2 that maintained clinical performance compared with singleplex assays. This protocol could streamline detection and decrease reagent use during current high SARS-CoV-2 testing demands.



KEYWORDS:

2019 novel coronavirus disease; COVID-19; SARS; SARS-CoV-2; coronavirus; coronavirus disease; molecular detection; rRT-PCR; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses


PMID:32294051DOI:10.3201/eid2607.201285
Free full text
 
Back
Top